Profund Advisors’s Inhibrx INBX Stock Holding History

Profund Advisors’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$532K	Sell	5,620 -1,412	-20%	-$141K	0.01%	538
2026 Q1	$473K	Buy	7,032 +3,761	+115%	+$279K	0.02%	567
2025 Q4	$258K	Buy	+3,271	New	+$223K	0.01%	987

Other funds holding INBX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Profund Advisors's INBX Position: Q2 2026 in Review

Profund Advisors reduced its Inhibrx (INBX) stake by 20% in Q2 2026, selling an estimated $141K and leaving 5,620 shares worth $532K. The position accounts for 0.01% of the portfolio, ranked #538.

Profund Advisors first reported a position in INBX in Q4 2025 and has held it in 3 quarters since. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

Profund Advisors held 5,620 shares of Inhibrx worth $532K as of Q2 2026.
Profund Advisors sold 1,412 Inhibrx shares in Q2 2026, an estimated $141K.
Inhibrx made up 0.01% of Profund Advisors's portfolio in Q2 2026, its #538 holding.
Profund Advisors first reported a position in Inhibrx in Q4 2025 and has held it in 3 quarters since.
163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.